Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs)

Pharmazie

Volumn 67, Issue 12, 2012, Pages 1002-1006

  Dong, Rui Hua ^a   Fang, Zhong Z E ^b,c   Zhu, Liang Liang ^b   Ge, Guang Bo ^b   Cao, Yun Feng ^b   Li, Xiao Bao ^a   Hu, Cui Min ^d   Yang, Ling ^b   Liu, Ze Yuan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARVACROL; CYTOCHROME P450; CYTOCHROME P450 2A6; DRUG METABOLIZING ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THYMOL;

ARTICLE; DRUG DETERMINATION; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME METABOLISM; OUTCOME ASSESSMENT;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROMES; ENZYME INHIBITORS; FEMALE; HUMANS; INDICATORS AND REAGENTS; ISOENZYMES; KINETICS; MALE; MICROSOMES, LIVER; MONOTERPENES; RECOMBINANT PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET; THYMOL;

EID: 84870342079     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.2534     Document Type: Article

References (25)

1. Austgulen L, Solheim E, Scheline RR (1987) Metabolism in rats of p-cymene derivatives: carvacrol and thymol. Pharmacol Toxicol 61: 98-102. (Pubitemid 17136709)
2. Chami F, Chami N, Bennis S, Trouillas J, Remmal A. (2004) Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother 54: 909-914. (Pubitemid 39529986)
3. Dong RH, Fang ZZ, Zhu LL, Liang SC, Ge GB, Yang L, Liu ZY (2012) Investigation of UDP- glucuronosyltransferases (UGTs) inhibitory properties of carvacrol. Phytother Res 26: 86-90.
4. Emoto C, Murase S, Sawada Y, Iwasaki K (2005) In vitro inhibitory effect of aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A. Drug Metab Pharmacokinet 20: 351-357.
5. Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L (2010) Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69: 193-199.
6. Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L (2011a) Identification of cytochrome P450 (CYP) isoforms involved in metabolism of corynoline, and assessment of its herb-drug interactions. Phytother Res 25: 256-263.
7. Fang ZZ, Zhang YY, Wang XL, Cao YF, Huo H, Yang L (2011b) Bioactivation of herbal constituents: simple alerts in the complex system. Expert Opin Drug Metab Toxicol 7(8): 989-1007.
8. Fukami T, Nakajima M, Higashi E, Yamanaka H, McLeod HL, Yokoi T (2005) A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity. Biochem Pharmacol 70: 801-808. (Pubitemid 41058715)
9. Godoy W, Albano R, Moraes EG, Pinho PR, Nunes RA, Saito EH, Higa C, Filho IM, Kruel CD, Schirmer CC, Gurski R, Lang MA, Pinto L (2002) CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to mitrosamine metabolism. Carcinogenesis 23: 611-616. (Pubitemid 34498499)
10. Guengerich FP (2006) Cytochrome P450 s and other enzymes in drug metabolism and toxicity. AAPS J 8: E101-E111.
11. Huang T, Fang ZZ, Yang L (2010) Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-Glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions (DDIs). Pharmazie 65: 919-921.
12. Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F, Raunio H (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 57: 1407-1413. (Pubitemid 29225104)
13. Lin JH, Lu AYH (1997) Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 49: 403-449. (Pubitemid 28030947)
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RL (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
15. Nafisi Sh, Hajiakhoondi A, Yektadoost A (2004) Thymol and carvacrol binding to DNA: mModel for drug-DNA interaction. Biopolymers 74: 345-351. (Pubitemid 39044775)
16. Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T (2006) Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 80: 282-297. (Pubitemid 44313906)
17. Oscarson M, McLellan RA, Gullsten H, Yue QY, Lang MA, Bernal ML, Sinues B, Hirvonen A, Raunio H, Pelkonen O, Ingelman-Sundberg M (1999) Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS L 448: 105-110. (Pubitemid 29153723)
18. Qu YQ, Fang ZZ,Yang L, Gao ZM, Liang R, Zhu LL, Dong PP, Zhang YY, Ge GB, Wang LM (2011) Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol. Pharmazie 66: 216-221.
19. Rae JM, Soukhova NV, Flockhart DA, Soukhova NV, Flockhart DA, Desta Z (2002) Triethylenethiophosphoramide is a specific inhibitor of cytochrome P4502B6: Implications for cyclophosphamide metabolism. Drug Metab Dispos 30: 525-530. (Pubitemid 34456973)
20. Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J (2010) Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 24: 1213-1216.
21. Veldhuizen EJA, Tjeerdsma-van bokhaven JLM, Zweijtzer C, Burt SA, Haagsman HP. (2006) Structural requirements for the antimicrobial activity of carvacrol. J Agric Food Chem 54: 1874-1879.
22. Walsky RL, Obach RS, Gaman EA, Gleeson JP, Proctor WR (2005) Selective inhibition of human cytochrome P450 2C8 by monlekucast. Drug Metab Dispos 33: 413-418. (Pubitemid 40279942)
23. Williams RT (1959) Detoxication mechanisms (2nd edn). Chapman and Hall: London; 300-301.
24. Yun CH, Shimada T, Guengerich FP (1991) Purification and characterization of human liver microsomal cytochrome P450 2A6. Mol Pharmacol 40: 679-685.
25. Zhang X, D'Agostino J, Wu H, Zhang QY, von Weymarn L, Murphy SE, Ding X (2007) CYP2A13: variable expression and role in human lung microsomal metabolism activation of the tobacco-specific carcinogen 4-(methylnitrosamine)-1-(3- pyridyl)-1-butanone. J Pharmacol Exp Ther 323: 570-578. (Pubitemid 350005129)